120 related articles for article (PubMed ID: 16485152)
1. The clinical value of parasternal sentinel node biopsy in breast cancer.
Leidenius MH; Krogerus LA; Toivonen TS; Leppänen EA; von Smitten KA
Ann Surg Oncol; 2006 Mar; 13(3):321-6. PubMed ID: 16485152
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection.
Borgstein PJ; Pijpers R; Comans EF; van Diest PJ; Boom RP; Meijer S
J Am Coll Surg; 1998 Mar; 186(3):275-83. PubMed ID: 9510258
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of axillary lymph-node metastases in patients with pure tubular carcinoma of the breast and sentinel node biopsy.
Leikola J; Heikkilä P; von Smitten K; Leidenius M
Eur J Surg Oncol; 2006 Jun; 32(5):488-91. PubMed ID: 16569494
[TBL] [Abstract][Full Text] [Related]
4. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.
De Cicco C; Cremonesi M; Luini A; Bartolomei M; Grana C; Prisco G; Galimberti V; Calza P; Viale G; Veronesi U; Paganelli G
J Nucl Med; 1998 Dec; 39(12):2080-4. PubMed ID: 9867145
[TBL] [Abstract][Full Text] [Related]
5. [Sentinel lymph node biopsy in breast cancer: the Lausanne experience].
Delaloye JF; Antonescu C; Besseghir N; Genton CY; Bischof-Delaloye A; De Grandi P
Rev Med Suisse Romande; 2000 Jun; 120(6):491-4. PubMed ID: 11014092
[TBL] [Abstract][Full Text] [Related]
6. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?
Brenot-Rossi I; Houvenaeghel G; Jacquemier J; Bardou VJ; Martino M; Hassan-Sebbag N; Pasquier J
J Nucl Med; 2003 Aug; 44(8):1232-7. PubMed ID: 12902412
[TBL] [Abstract][Full Text] [Related]
7. Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer.
van der Ent FW; Kengen RA; van der Pol HA; Hoofwijk AG
Eur J Surg Oncol; 1999 Feb; 25(1):24-9. PubMed ID: 10188850
[TBL] [Abstract][Full Text] [Related]
8. Results of a standardized protocol for sentinel node imaging in breast cancer with Tc-99m labeled nanocolloidal albumin.
Rink T; Heuser T; Fitz H; Schroth HJ; Weller E; Zippel HH
Nuklearmedizin; 2001 Jun; 40(3):80-5. PubMed ID: 11475077
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification.
Valdés-Olmos RA; Jansen L; Hoefnagel CA; Nieweg OE; Muller SH; Rutgers EJ; Kroon BB
J Nucl Med; 2000 Sep; 41(9):1500-6. PubMed ID: 10994729
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node identification in breast cancer patients.
Fonti R; Limite G; Sodano A; Riccardi A; Forestieri P; De Cristofaro G; Pettinato G; Salvatore M
Radiol Med; 2002 Apr; 103(4):370-7. PubMed ID: 12107387
[TBL] [Abstract][Full Text] [Related]
11. Optimized sentinel node scintigraphy in breast cancer.
Paganelli G; De Cicco C; Cremonesi M; Prisco G; Calza P; Luini A; Zucali P; Veronesi U
Q J Nucl Med; 1998 Mar; 42(1):49-53. PubMed ID: 9646645
[TBL] [Abstract][Full Text] [Related]
12. A second radioisotope injection enhances intraoperative sentinel node identification in breast cancer patients without visualized nodes on preoperative lymphoscintigraphy.
Leikola JP; Leppänen EA; von Smitten KA; Leidenius MH
Acta Radiol; 2006 Oct; 47(8):760-3. PubMed ID: 17050353
[TBL] [Abstract][Full Text] [Related]
13. The impact on post-surgical treatment of sentinel lymph node biopsy of internal mammary lymph nodes in patients with breast cancer.
Madsen E; Gobardhan P; Bongers V; Albregts M; Burgmans J; De Hooge P; Van Gorp J; van Dalen T
Ann Surg Oncol; 2007 Apr; 14(4):1486-92. PubMed ID: 17253106
[TBL] [Abstract][Full Text] [Related]
14. The effect of patient and tumour characteristics on visualization of sentinel nodes after a single intratumoural injection of Tc 99m labelled human albumin colloid in breast cancer.
Leppänen E; Leidenius M; Krogerus L; von Smitten K
Eur J Surg Oncol; 2002 Dec; 28(8):821-6. PubMed ID: 12477472
[TBL] [Abstract][Full Text] [Related]
15. Peritumoural versus subareolar administration of technetium-99m nanocolloid for sentinel lymph node detection in breast cancer: preliminary results of a prospective intra-individual comparative study.
Maza S; Valencia R; Geworski L; Zander A; Guski H; Winzer KJ; Munz DL
Eur J Nucl Med Mol Imaging; 2003 May; 30(5):651-6. PubMed ID: 12612811
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
17. Additional tracer injection to improve the technical success rate of lymphoscintigraphy for sentinel node biopsy in breast cancer.
Heuts EM; van der Ent FW; van der Pol HA; von Meyenfeldt MF; Voogd AC
Ann Surg Oncol; 2009 May; 16(5):1156-63. PubMed ID: 19259741
[TBL] [Abstract][Full Text] [Related]
18. Number of metastatic sentinel nodes as predictor of axillary involvement in patients with breast cancer.
Zavagno G; De Salvo GL; Bozza F; Scalco G; Marconato R; Valletta S; Racano C; Burelli P; Nitti D; Lise M
Breast Cancer Res Treat; 2004 Jul; 86(2):171-9. PubMed ID: 15319569
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-Tetrofosmin pinhole-SPECT (P-SPECT) and radioguided sentinel node (SN) biopsy and in breast cancer axillary lymph node staging.
Spanu A; Dettori G; Chessa F; Porcu A; Cottu P; Solinas P; Falchi A; Solinas ME; Scanu AM; Nuvoli S; Madeddu G
Cancer Biother Radiopharm; 2001 Dec; 16(6):501-13. PubMed ID: 11789027
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
Goyal A; Newcombe RG; Chhabra A; Mansel RE;
Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
